Meijer L - Search Results

1

Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?

Hochard A, Oumata N, Bettayeb K, Gloulou O, Fant X, Durieu E, Buron N, Porceddu M, Borgne-Sanchez A, Galons H, Flajolet M, Meijer L. Hochard A, et al. Among authors: meijer l. J Alzheimers Dis. 2013;35(1):107-20. doi: 10.3233/JAD-121777. J Alzheimers Dis. 2013. PMID: 23364140 Free PMC article.

2

Isolation of drugs active against mammalian prions using a yeast-based screening assay.

Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H, Dormont D, Meijer L, Cullin C, Blondel M. Bach S, et al. Among authors: meijer l. Nat Biotechnol. 2003 Sep;21(9):1075-81. doi: 10.1038/nbt855. Epub 2003 Aug 10. Nat Biotechnol. 2003. PMID: 12910243

3

Pharmacological inhibitors of glycogen synthase kinase 3.

Meijer L, Flajolet M, Greengard P. Meijer L, et al. Trends Pharmacol Sci. 2004 Sep;25(9):471-80. doi: 10.1016/j.tips.2004.07.006. Trends Pharmacol Sci. 2004. PMID: 15559249 Review.

4

7-Bromoindirubin-3'-oxime induces caspase-independent cell death.

Ribas J, Bettayeb K, Ferandin Y, Knockaert M, Garrofé-Ochoa X, Totzke F, Schächtele C, Mester J, Polychronopoulos P, Magiatis P, Skaltsounis AL, Boix J, Meijer L. Ribas J, et al. Among authors: meijer l. Oncogene. 2006 Oct 12;25(47):6304-18. doi: 10.1038/sj.onc.1209648. Epub 2006 May 15. Oncogene. 2006. PMID: 16702956 Free article.

5

3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.

Ferandin Y, Bettayeb K, Kritsanida M, Lozach O, Polychronopoulos P, Magiatis P, Skaltsounis AL, Meijer L. Ferandin Y, et al. Among authors: meijer l. J Med Chem. 2006 Jul 27;49(15):4638-49. doi: 10.1021/jm060314i. J Med Chem. 2006. PMID: 16854069

6

Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography.

Guiffant D, Tribouillard D, Gug F, Galons H, Meijer L, Blondel M, Bach S. Guiffant D, et al. Among authors: meijer l. Biotechnol J. 2007 Jan;2(1):68-75. doi: 10.1002/biot.200600223. Biotechnol J. 2007. PMID: 17225251

7

Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases.

Bettayeb K, Tirado OM, Marionneau-Lambot S, Ferandin Y, Lozach O, Morris JC, Mateo-Lozano S, Drueckes P, Schächtele C, Kubbutat MH, Liger F, Marquet B, Joseph B, Echalier A, Endicott JA, Notario V, Meijer L. Bettayeb K, et al. Among authors: meijer l. Cancer Res. 2007 Sep 1;67(17):8325-34. doi: 10.1158/0008-5472.CAN-07-1826. Cancer Res. 2007. PMID: 17804748

8

CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.

Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L. Bettayeb K, et al. Among authors: meijer l. Oncogene. 2008 Oct 2;27(44):5797-807. doi: 10.1038/onc.2008.191. Epub 2008 Jun 23. Oncogene. 2008. PMID: 18574471

9

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

Oumata N, Bettayeb K, Ferandin Y, Demange L, Lopez-Giral A, Goddard ML, Myrianthopoulos V, Mikros E, Flajolet M, Greengard P, Meijer L, Galons H. Oumata N, et al. Among authors: meijer l. J Med Chem. 2008 Sep 11;51(17):5229-42. doi: 10.1021/jm800109e. Epub 2008 Aug 13. J Med Chem. 2008. PMID: 18698753

10

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.

Bettayeb K, Sallam H, Ferandin Y, Popowycz F, Fournet G, Hassan M, Echalier A, Bernard P, Endicott J, Joseph B, Meijer L. Bettayeb K, et al. Among authors: meijer l. Mol Cancer Ther. 2008 Sep;7(9):2713-24. doi: 10.1158/1535-7163.MCT-08-0080. Mol Cancer Ther. 2008. PMID: 18790752 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page